ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 225 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $360,036 | -41.1% | 27,400 | -43.5% | 0.00% | -33.3% |
| Q2 2023 | $611,100 | -42.5% | 48,500 | -40.4% | 0.01% | -45.5% |
| Q1 2023 | $1,062,270 | -44.0% | 81,400 | -24.3% | 0.01% | -45.0% |
| Q4 2022 | $1,896,300 | +144.1% | 107,500 | +110.8% | 0.02% | +122.2% |
| Q3 2022 | $776,730 | -31.7% | 51,000 | +1.0% | 0.01% | -18.2% |
| Q1 2022 | $1,137,000 | -34.6% | 50,500 | -46.4% | 0.01% | -8.3% |
| Q4 2021 | $1,738,000 | -21.5% | 94,200 | -43.2% | 0.01% | -47.8% |
| Q3 2021 | $2,215,000 | +75.5% | 165,700 | +143.0% | 0.02% | +91.7% |
| Q2 2021 | $1,262,000 | +210.1% | 68,200 | +151.7% | 0.01% | +200.0% |
| Q1 2021 | $407,000 | -50.9% | 27,100 | -77.0% | 0.00% | -63.6% |
| Q1 2020 | $829,000 | -4.2% | 117,700 | +33.6% | 0.01% | +22.2% |
| Q4 2019 | $865,000 | +84.8% | 88,100 | +140.1% | 0.01% | +50.0% |
| Q2 2017 | $468,000 | +17.3% | 36,700 | +9.9% | 0.01% | 0.0% |
| Q1 2015 | $399,000 | – | 33,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 11,000,000 | $163,570,000 | 8.77% |
| Blue Harbour Group | 7,262,346 | $107,991,000 | 8.08% |
| RIVULET CAPITAL, LLC | 265,000 | $3,941,000 | 4.12% |
| Breithorn Capital Management | 336,760 | $5,008,000 | 2.92% |
| EMINENCE CAPITAL, LP | 7,791,132 | $115,854,000 | 2.56% |
| Chinook Capital Management | 76,275 | $1,134,000 | 1.73% |
| GARGOYLE INVESTMENT ADVISOR L.L.C. | 198,008 | $2,657,000 | 1.64% |
| Adirondack Research & Management Inc. | 190,749 | $2,836,000 | 1.63% |
| INTREPID CAPITAL MANAGEMENT INC /DE/ | 100,000 | $1,487,000 | 1.05% |
| PRICE MICHAEL F | 477,500 | $7,100,000 | 0.94% |